Jefferies Group LLC Trevena Inc Transaction History

Jefferies Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $47,304 - $72,900	-32,400 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.77 - $2.93 $57,348 - $94,932	32,400 New	32,400 $58,000
Q1 2018 May 15, 2018	SELL	$1.51 - $2.06 $21,895 - $29,870	-14,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.4 - $2.6 $20,300 - $37,700	14,500	14,500 $23,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.